Shraga-Heled N - Search Results

1

Semaphorins in cancer.

Neufeld G, Shraga-Heled N, Lange T, Guttmann-Raviv N, Herzog Y, Kessler O. Neufeld G, et al. Among authors: shraga heled n. Front Biosci. 2005 Jan 1;10:751-60. doi: 10.2741/1569. Print 2005 Jan 1. Front Biosci. 2005. PMID: 15569615 Review.

2

Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.

Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G. Guttmann-Raviv N, et al. Among authors: shraga heled n. J Biol Chem. 2007 Sep 7;282(36):26294-305. doi: 10.1074/jbc.M609711200. Epub 2007 Jun 14. J Biol Chem. 2007. PMID: 17569671 Free article.

3

Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor.

Shraga-Heled N, Kessler O, Prahst C, Kroll J, Augustin H, Neufeld G. Shraga-Heled N, et al. FASEB J. 2007 Mar;21(3):915-26. doi: 10.1096/fj.06-6277com. Epub 2006 Dec 21. FASEB J. 2007. PMID: 17185751

4

The neuropilins and their role in tumorigenesis and tumor progression.

Guttmann-Raviv N, Kessler O, Shraga-Heled N, Lange T, Herzog Y, Neufeld G. Guttmann-Raviv N, et al. Among authors: shraga heled n. Cancer Lett. 2006 Jan 8;231(1):1-11. doi: 10.1016/j.canlet.2004.12.047. Cancer Lett. 2006. PMID: 16356825 Review.

5

Semaphorin-3F is an inhibitor of tumor angiogenesis.

Kessler O, Shraga-Heled N, Lange T, Gutmann-Raviv N, Sabo E, Baruch L, Machluf M, Neufeld G. Kessler O, et al. Among authors: shraga heled n. Cancer Res. 2004 Feb 1;64(3):1008-15. doi: 10.1158/0008-5472.can-03-3090. Cancer Res. 2004. PMID: 14871832 Free article.

6

Human Placental-Derived Adherent Stromal Cells Co-Induced with TNF-α and IFN-γ Inhibit Triple-Negative Breast Cancer in Nude Mouse Xenograft Models.

Allen H, Shraga-Heled N, Blumenfeld M, Dego-Ashto T, Fuchs-Telem D, Gilert A, Aberman Z, Ofir R. Allen H, et al. Among authors: shraga heled n. Sci Rep. 2018 Jan 12;8(1):670. doi: 10.1038/s41598-017-18428-1. Sci Rep. 2018. PMID: 29330447 Free PMC article.

7

Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1.

Prahst C, Héroult M, Lanahan AA, Uziel N, Kessler O, Shraga-Heled N, Simons M, Neufeld G, Augustin HG. Prahst C, et al. Among authors: shraga heled n. J Biol Chem. 2008 Sep 12;283(37):25110-25114. doi: 10.1074/jbc.C800137200. Epub 2008 Jul 15. J Biol Chem. 2008. PMID: 18628209 Free PMC article.

8

In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications.

Betzer O, Meir R, Dreifuss T, Shamalov K, Motiei M, Shwartz A, Baranes K, Cohen CJ, Shraga-Heled N, Ofir R, Yadid G, Popovtzer R. Betzer O, et al. Among authors: shraga heled n. Sci Rep. 2015 Oct 28;5:15400. doi: 10.1038/srep15400. Sci Rep. 2015. PMID: 26507853 Free PMC article.

9

Prostaglandin receptor EP₁-mediated differential degradation of cyclooxygenases involves a specific lysine residue.

Spector-Chotiner A, Shraga-Heled N, Sood R, Rimon G, Barki-Harrington L. Spector-Chotiner A, et al. Among authors: shraga heled n. Biochem Biophys Res Commun. 2014 Jan 10;443(2):738-42. doi: 10.1016/j.bbrc.2013.12.038. Epub 2013 Dec 12. Biochem Biophys Res Commun. 2014. PMID: 24333447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results